GSK

  • Glaxo settles healthcare fraud case for $3 billion July 3, 2012

    Washington: GlaxoSmithKline Plc agreed to plead guilty to misdemeanor criminal charges and pay $3 billion to settle what government officials on Monday described as the largest case of healthcare fraud in US history. The agreement, which still needs court approval, would resolve allegations that the British drugmaker broke US laws in...
  • GSK faces Q4 profit wipeout on $3 billion legal hit January 18, 2011

    London: GlaxoSmithKline will record a legal charge of 2.2 billion pounds ($3.4 billion) for the fourth quarter, effectively wiping out its profit, as it settles further claims related to Avandia and sales practices. The charge equates to an aftertax cost of 1.8 billion pounds, more than the 1.45 billion the...